Mentor: Peter Bitterman, MD
Title of Research Project:
Translational control and its involvement in epithelial to mesenchymal transition in lung epithelial cells.
Education: 1979 – 1983, B.S., Purdue University
1983 – 1986, M.S., University of Illinois,
Champaign-Urbana, IL
1986 – 1991, Ph.D., University of Illinois,
Champaign-Urbana, IL
Specific Aims:
Aim 1. To investigate the involvement of translational regulation in EMT in human epithelial lung cells.
A. Express the translationally-limiting factor, eif4E, in immortalizing human lung epithelial cells and determine if this intervention changes the epithelial cell behavior or epithelial/mesenchymal marker expression of the cells.
B. In the established model of TGF-b- induced EMT in human lung A549 cells, decrease expression of eif4E using shRNA knockdown and examine the effect on EMT and epithelial/mesenchymal cell marker expression.
Aim 2. To investigate ILEI/FAM3C’s involvement in EMT in human epithelial lung cells.
A. In the established model of TGF-b- induced EMT in human lung A549 cells, decrease expression of FAM3C using shRNA knockdown and examine the effect on epithelial/mesenchymal cell marker expression and EMT.
B. Express epitope-tagged human FAM3C in immortalized human lung epithelial cells and examine the effect of FAM3C expression on epithelial/mesenchymal cell marker expression and EMT.
Course Work:
Course #: LaMP 4177
Course Description: Pathology for Allied Health
Completed: August 2007
Publications:
Larsson O, Li S, Issaenko OS, Avdulov S, Peterson M, Smith K, Bitterman PB, Polunovsky VA. eIF4E-induced progression of primary HMECs along the cancer pathway is associated with targeted translational deregulation of oncogenic drivers and inhibitors. Cancer Res 2007; 67(14): 6814-24.
Last updated 3/27/2008